DPI-FORMULIERUNG MIT SULFOALKYLETHERCYCLODEXTRIN
European patent · EP3520779 · Deleted
Register entry
- Publication number
- EP3520779
- Application number
- EP18214449
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Apr 22, 2005
- Published
- Aug 7, 2019
- Granted
- Dec 22, 2021
- Deleted
- Apr 22, 2025
- Reason
- Maximum term reached
- IPC classes
- A61K 9/12 (2006.01)A61K 9/14 (2006.01)C08B 37/16 (2006.01)A61K 47/40 (2006.01)A61P 5/40 (2006.01)A61P 11/00 (2006.01)A61P 11/06 (2006.01)A61P 29/00 (2006.01)A61P 37/08 (2006.01)A61P 43/00 (2006.01)
- Priority
- US 56489204 P 23.04.2004
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 22, 2025
Maximum term reached
- Status of protective title
- Active → Cancelled
- Cancellation date
- 22.04.2025
- Cause for cancellation
- Expiry of maximum term of protection
Published in Swissreg on 22.04.2025
- May 1, 2024
Change
Published in Swissreg on 01.05.2024
- May 1, 2023
Change
Published in Swissreg on 01.05.2023
- Nov 2, 2022
Change
Published in Swissreg on 02.11.2022
- Mar 22, 2022
Address changed
- Owner
- CyDex Pharmaceuticals, Inc., 3911 Sorrento Valley Boulevard, Suite 110, San Diego, CA 92121, USA → CyDex Pharmaceuticals, Inc., 5980 Horton Street, Suite 405, Emeryville, CA 94608, USA
Published in Swissreg on 22.03.2022
- Dec 22, 2021
Granted
Published in Swissreg on 22.12.2021
Parties
Inventor
HECKER, Douglas B
Liberty, MO 64068, US
MOSHER, Gerold L.
Kansas City, MO 64145, US
PIPKIN, James D
Lawrence, KS 66049, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.